We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Sema4 Holdings Corp is a patient-centered health intelligence company dedicated to advancing healthcare through data-driven insights. It is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health ... Sema4 Holdings Corp is a patient-centered health intelligence company dedicated to advancing healthcare through data-driven insights. It is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. Show more
Company expects to exceed 2022 revenue target with strong momentum to deliver continued growth in 2023 combining GeneDx and Centrellis® platforms Company’s common stock will trade on the Nasdaq...
STAMFORD, Conn., Dec. 30, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), a health insights company, today announced the company will participate in the 41st Annual J.P. Morgan Healthcare...
STAMFORD, Conn., Dec. 05, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), a health insights company, today announced the results of a new study on mitochondrial diseases in newborns. The findings...
Company will focus on its high growth, high margin pediatric and rare disease business, powered by whole exome/genome diagnostic testing and analysis and data-driven insights from Centrellis® 19...
STAMFORD, Conn., Nov. 04, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), a health insights company, today announced it will release financial results for the third quarter of 2022 before the...
SMFR SHAREHOLDER ALERT: Jakubowitz Law Reminds Sema4 Holdings Corp. Shareholders of a Lead Plaintiff Deadline of November 7, 2022 PR Newswire NEW YORK, Nov. 4, 2022 NEW YORK, Nov. 4, 2022...
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Sema4 Holdings Corp. - SMFR PR Newswire CEDARHURST, N.Y., Nov. 2, 2022 CEDARHURST, N.Y., Nov. 2, 2022...
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Sema4 Holdings, Corp. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 7, 2022 - (NASDAQ: SMFR) PR Newswire NEW...
STAMFORD, Conn., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), a health insights company, supports the new National Society of Genetic Counselors guidelines recommending exome...
SMFR SHAREHOLDER ALERT: Jakubowitz Law Reminds Sema4 Holdings Corp. Shareholders of a Lead Plaintiff Deadline of November 7, 2022 PR Newswire NEW YORK, Oct. 28, 2022 NEW YORK, Oct. 28, 2022...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions